Moderna, Inc(NASDAQ:MRNA) 
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. As of March 9, 2021, the company had 13 programs in clinical trials and a tot...
Website: http://www.modernatx.com
Founded: 2010
IPO Price: $23 (Dec 07, 2018)
Full Time Employees: 3,900 (Dec 2022)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 25.29
H 25.77
L 23.76
C 25.11
V 16,041,332
10EMA 25.11
20EMA 25.11
60EMA 25.11
120EMA 25.11
250EMA 25.11